IRX-010

· ImmunoRx Pharma Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for IRX-010, covering 2025-03-26 to 2025-03-26. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics Following Intravenous Administration of IRX-010 in Healthy Participants [Phase 1]

See pricing